Regeneron to Acquire 23andMe for $256M
Regeneron Pharmaceuticals has agreed to acquire 23andMe’s consumer genetics business and assets for $256 million, following 23andMe’s Chapter 11 bankruptcy.
More Videos
Would You Let AI Judge You? Inside the Digital Confession Booth Turning Heads At Tribeca Immersive
The provocative new installation from artist duo MOTS will make you question everything you know about technology
How Nintendo Switch 2 Broke Video Game Consoling Sales Records
Mark Spoonauer, Global Editor-In-Chief at Tom's Guide, discusses the craze behind the latest Nintendo Switch 2 and why it already flying off shelves. Watch!
An Expert Gives You an In-Depth Look at the Markets This Week
Bob Lang, Chief Options Strategist at Explosive Options, joins J.D. Durkin on the floor of the NYSE for a look at how traders are approaching the markets.
Inside the Inspiration Behind the Solid Gold Exhibit at the Brooklyn Museum
Matthew Yokobosky, Senior Curator, Fashion and Material Culture at Brooklyn Museum, explains why you need to some see the Solid Gold exhibit with your own eyes!
Inside Disney Taking Full Control of Hulu
Seth Schachner, Managing Director at Strat Americas, talks Disney's taking control of Hulu, Warner Bros. and Discovery's split and how if affects the viewers.
TAPPP Is Changing the Game: The Future of Interactive Sports Entertainment Is Here
Sandy Agarwal, Founder & CEO of TAPPP, discusses how his company offers a suite of TV viewing enhancement apps such as shopping, betting and contests.
